USFDA closes out warning letter issued to Divis Laboratories

10 Nov 2017 Evaluate

The US Food and Drug Administration (USFDA) has completed evaluation of Divis Laboratories corrective actions in response to its Warning Letter dated April 13, 2017. The agency has closed-out the warning letter.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

4025.35 184.60 (4.81%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.